Can a personalized exercise plan boost heart rehab for seniors?
NCT ID NCT05925634
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This trial tests whether a personalized exercise prescription, based on a graded exercise test and target heart rate, improves fitness more than standard perceived exertion-based exercise in older adults (60+) recovering from heart events like heart attacks or heart surgery. Participants will be randomly assigned to one of two exercise groups and attend at least 18 cardiac rehab sessions. The study measures changes in walking ability, strength, and balance, and also explores how psychological feedback affects exercise habits and long-term outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Personalized exercise prescription based on a graded exercise test and target heart rate range, compared to standard perceived exertion-based exercise
- What this could lead to
- If personalized exercise prescriptions improve fitness more than standard methods, this could lead to better cardiac rehab outcomes for older adults, potentially reducing future heart problems.
- What could go wrong
- This is a behavioral intervention, and results may vary. The trial is not a cure and focuses on improving fitness; individual responses to exercise can differ, and long-term benefits are not guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 320 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2023
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who are eligible for cardiac rehabilitation by having had a cardiac event such as a myocardial infarction (heart attack), heart failure, percutaneous coronary intervention or angioplasty with stent, coronary artery bypass graft, or heart valve surgery in the past 6 months. * Lives in, or plans to reside in, the Springfield, MA, or greater Detroit, MI, area for the next year. * Recruited from a Phase 2 Cardiac Rehabilitation Center at either Baystate Medical Center or Henry Ford Health System. * Age ≥ 60 years * Agrees to attend at least 18 sessions of cardiac rehabilitation after randomization * Agrees to attend cardiac rehabilitation at least twice a week Exclusion Criteria: These include conditions that alter the physiology and monitoring of resting and exercise heart rate. These also include conditions that might limit an individual's ability to exercise. * Permanent atrial fibrillation * Heart transplant * Left-ventricular assist devices * Stable angina * High-risk un-revascularized coronary artery disease * Symptomatic peripheral artery disease * Aortic and/or mitral stenosis * Any condition where exercise testing or training might be unsafe or limited
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac valve surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaler boost heart pumping in COPD patients?
- Can zapping the heart beat drugs for AF in heart failure?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?